Ford HT - Search Results

1

Adjuvant aminoglutethimide for postmenopausal patients with primary breast cancer: analysis at 8 years.

Jones AL, Powles TJ, Law M, Tidy A, Easton D, Coombes RC, Smith IE, McKinna JA, Nash A, Ford HT, et al. Jones AL, et al. Among authors: ford ht. J Clin Oncol. 1992 Oct;10(10):1547-52. doi: 10.1200/JCO.1992.10.10.1547. J Clin Oncol. 1992. PMID: 1403034 Clinical Trial.

2

Comparison of conservative surgery and radiotherapy with mastectomy in the treatment of early breast cancer.

Rayter Z, Gazet JC, Ford HT, Easton DF, Coombes RC. Rayter Z, et al. Among authors: ford ht. Eur J Surg Oncol. 1990 Dec;16(6):486-92. Eur J Surg Oncol. 1990. PMID: 2253793

3

Adjuvant aminoglutethimide therapy for postmenopausal patients with primary breast cancer.

Coombes RC, Powles TJ, Easton D, Chilvers C, Ford HT, Smith IE, McKinna A, White H, Bradbeer J, Yarnold J, et al. Coombes RC, et al. Among authors: ford ht. Cancer Res. 1987 May 1;47(9):2494-7. Cancer Res. 1987. PMID: 3552216 Clinical Trial.

4

Aminoglutethimide for the treatment of advanced postmenopausal breast cancer.

Harris AL, Powles TJ, Smith IE, Coombes RC, Ford HT, Gazet JC, Harmer CL, Morgan M, White H, Parsons CA, McKinna JA. Harris AL, et al. Among authors: ford ht. Eur J Cancer Clin Oncol. 1983 Jan;19(1):11-17. doi: 10.1016/0277-5379(83)90390-5. Eur J Cancer Clin Oncol. 1983. PMID: 6682769

5

A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer.

Makris A, Powles TJ, Ashley SE, Chang J, Hickish T, Tidy VA, Nash AG, Ford HT. Makris A, et al. Among authors: ford ht. Ann Oncol. 1998 Nov;9(11):1179-84. doi: 10.1023/a:1008400706949. Ann Oncol. 1998. PMID: 9862047 Free article. Clinical Trial.

6

Aminoglutethimide in treatment of metastatic breast carcinoma.

Smith IE, Fitzharris BM, McKinna JA, Fahmy DR, Nash AG, Neville AM, Gazet JC, Ford HT, Powles TJ. Smith IE, et al. Among authors: ford ht. Lancet. 1978 Sep 23;2(8091):646-9. doi: 10.1016/s0140-6736(78)92759-9. Lancet. 1978. PMID: 80576

7

Premarin in the management of metastatic breast carcinoma in post-menopausal patients.

Smith IE, Ford HT, Gazet JC, Powles TJ. Smith IE, et al. Among authors: ford ht. Clin Oncol. 1979 Jun;5(2):159-62. Clin Oncol. 1979. PMID: 223791 No abstract available.

8

Carboplatin, etoposide, and ifosfamide as intensive chemotherapy for small-cell lung cancer.

Smith IE, Perren TJ, Ashley SA, Woodiwiss J, Forgeson GV, Yarnold JR, Ford HT. Smith IE, et al. Among authors: ford ht. J Clin Oncol. 1990 May;8(5):899-905. doi: 10.1200/JCO.1990.8.5.899. J Clin Oncol. 1990. PMID: 2159056

9

Treatment of disseminated breast cancer with tamoxifen, aminoglutethimide, hydrocortisone, and danazol, used in combination or sequentially.

Powles TJ, Ashley S, Ford HT, Gazet JC, Nash AG, Neville AM, Coombes RC. Powles TJ, et al. Among authors: ford ht. Lancet. 1984 Jun 23;1(8391):1369-73. doi: 10.1016/s0140-6736(84)91872-5. Lancet. 1984. PMID: 6145832 Clinical Trial.

10

Adjuvant aminoglutethimide therapy for postmenopausal patients with primary breast cancer: progress report.

Coombes RC, Chilvers C, Dowsett M, Gazet JC, Ford HT, Bettelheim R, Gordon C, Smith IE, Zava D, Powles TJ. Coombes RC, et al. Among authors: ford ht. Cancer Res. 1982 Aug;42(8 Suppl):3415s-3419s. Cancer Res. 1982. PMID: 6211228 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

105 results

Search Page